RGEN Q4 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$69M+33.8% YoY

Gross Profit

$36M51.2% margin

Operating Income

$6M8.5% margin

Net Income

$4M5.2% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$340M

Stockholders' Equity

$1.1B

Cash & Equivalents

$528M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$52M	+33.8%
Gross Profit	$36M	$29M	+23.1%
Operating Income	$6M	$8M	-24.9%
Net Income	$4M	$6M	-36.1%

Revenue Segments

Product

$69M100%

Royalty

$78,0000%